Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to finalize development of a questionnaire that measures health-related symptoms and concerns for persons diagnosed with, and either treated or monitored for, anal pre-cancer lesions.

Official Title
-----------------
Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

Conditions
-----------------
Anal High-Grade Squamous Intraepithelial Lesions

Intervention / Treatment
-----------------
* Behavioral: Assessment of Health-Related Quality


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Consented to the ANCHOR trial as per self-report and by providing a valid referral code on the information sheet provided by the referring site. Both men and women from the ANCHOR trial will be recruited to this study. English fluent as we are only validating this measure in English at this time At least one month post-treatment for anal HSIL as per self-report, or if the person is in the ANCHOR trial observation arm, then at least one month post- randomization. Within two weeks post initial-treatment for anal HSIL on ANCHOR study or within two weeks post-randomization to ANCHOR study as per self-report. NOTES: ANCHOR participants who are randomized to the treatment arm must have completed initial treatment and are within two weeks of initial treatment completion. ANCHOR participants who were treated initially with topical treatment are only eligible within two weeks after the last topical treatment application. ANCHOR participants who were treated initially with both topical and ablation treatments are eligible within two weeks of completing both treatments. ANCHOR participants who are randomized to the active monitoring arm are eligible if they are within two weeks of randomization Exclusion Criteria: Has a scheduled ANCHOR follow-up appointment in the next two weeks as per self report. The purpose of this exclusion criterion is to minimize the impact on a participant's responses to a post-test evaluation the potential occurrence of an interim diagnosis or treatment event, or anxiety related to an upcoming medical follow-up.

Ages Eligible for Study
-----------------
Minimum Age: 35 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Behavioral: Assessment of Health-Related Quality|Demographic Questionnaire, ANCHOR HRSI, FACT-G, MDASI, Patient ECOG PS, PGIC|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| degree of test-retest reliability in the ANCHOR HRSI | measure from the initial assessment point to the 7-10 day follow-up. | 7-10 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Health-Related Symptom Index, ANCHOR( ANal Cancer HSIL (high grade squamous intraepithelial lesions) Outcomes Research study)